My Profile e-Learning Center my.ASTHO Contact Us

Filter Results

Clear All Filters

Topic

Product Type

Location

Contributor

Published Date

Displaying 3 results for

GO
Search Filters: Policy cancel Beth Giambrone cancel New Jersey cancel New York cancel Illinois cancel

2022 Legislative Session Update: Part Two

Blog,
Health Policy Update,
Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
STIs,
HIV,
Tobacco Control,
Mental Health,
Environmental Health,
Food and Water Safety,
PFAS,
Health Equity,
Rural Health,
Infectious Disease,
West Virginia,
Wyoming,
New Jersey,
California,
Washington, D.C.,
New York,
Colorado,
Connecticut,
Hawaii,
Illinois,
Indiana,
Rhode Island,
Minnesota,
Washington,
Maryland,
Parker Beene,
Maggie Davis,
Beth Giambrone

The ASTHO State Health Policy team provides brief updates on 5 of the ten state health policy issues to watch in 2022: mental and behavioral health, rural health, e-cigarettes and flavored tobacco products, HIV and PFAS.

ASTHO Policy Watch 2022: E-Cigarettes and Flavored Tobacco Products

Blog,
Health Policy Update,
Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Tobacco Control,
Health Equity,
At-Risk Populations,
Elimination of Disparities,
California,
Illinois,
Massachusetts,
Michigan,
New Jersey,
New York,
Rhode Island,
Utah,
Washington, D.C.,
Beth Giambrone

Each year, ASTHO notes the top public health policy issues to watch in the upcoming year. ASTHO has published a prospectus on several issues, with more coming later this month. ASTHO kicked off its top 10 public health state policy issues ...

Increasing Naloxone Accessibility to Prevent Opioid Overdoses

Blog,
Health Policy Update,
Policy,
State Health Policy,
Population Health and Prevention,
Social and Behavioral Health,
Substance Misuse,
Opioids,
Overdose Prevention,
Arkansas,
Delaware,
Illinois,
Maine,
Nevada,
New Jersey,
North Carolina,
Virginia,
Andy Baker-White,
Beth Giambrone,
New York,
Infectious Disease,
COVID-19,
COVID and Mental Health

With data showing the number of the opioid overdose deaths escalated during the COVID-19 pandemic, access to naloxone, a medication that can reverse an opioid overdose, continues to be an important topic for policy makers. The number of ...